Article Information
History
- February 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Yuan Lu, ScD1,2,
- Chenxi Huang, PhD1,2,
- Yuntian Liu, MPH1,
- César Caraballo, MD1,2,
- Shiwani Mahajan, MBBS, MHS1,2,
- Daisy Massey, BA1,2,
- Erica S. Spatz, MD, MHS1,2,
- Oyere Onuma, MD, MSc1,2,
- Joseph S. Ross, MD, MHS1,3,4,
- Wade L. Schulz, MD, PhD1,5,6 and
- Harlan M. Krumholz, MD, SM.1,2,4,*
- 1Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT
- 2Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
- 3Section of General Internal Medicine, Yale School of Medicine, New Haven, CT
- 4Department of Health Policy and Management, Yale School of Public Health, New Haven, CT
- 5Center for Medical Informatics, Yale School of Medicine, New Haven, CT
- 6Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT
- ↵*Corresponding author:
Harlan M. Krumholz, MD, SM, 195 Church St, 5th Floor, New Haven, CT, 06510, Phone: 203-497-1246, Email: harlan.krumholz{at}yale.edu
Posted February 17, 2022.
Medication Guideline Adherence Among Patients with Markedly Elevated Blood Pressure in A Real-World Setting
